Hat mitgewirkt an:
-
Phänotypisierung neurodegenerativer Erkrankungen am Beispiel der Alzheimer-Erkrankung
-
Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer’s disease
-
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
-
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)